Clinical Trials: Impact & Quality

Banner Image

CT:IQ aims to develop and implement recommendations that will improve the impact, quality and efficiency of clinical trials, leading to more rapid, lower cost and higher quality evaluation of healthcare interventions in Australia.

This project will engage the clinical trial industry in Australia to determine the actions needed to strengthen Australia as an attractive clinical trial research destination. The project will determine at least two activities in year one and three in year two as a focus to achieve an improved national clinical trial sector.

Outcomes (FY2020):

  • Five sector wide, industry led projects are complete, including checklist and additional information for clinical trial design and an investigation onto electronic consent. 
  • The consortium have presented its projects at 9 events to over 1,000 attendees.

Visit CT:IQ for more information

Twitter: @CTImpactQuality

LinkedIn: CT:IQ

Consortium LeadBellbery Limited
Consortium Members

ACTA, NHMRC CTC and The George Institute with an additional 25 organisations representing the diverse clinical trials sector.

MTPConnect Grant$370,000
Industry Contribution$430,000
Project Duration

January 2018 – March 2021 


Leanne Weekes, CT:IQ -